TYDESSIA Trademark

Trademark Overview

On Tuesday, December 15, 2015, a trademark application was filed for TYDESSIA with the United States Patent and Trademark Office. The USPTO has given the TYDESSIA trademark a serial number of 86850072. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 26, 2019. This trademark is owned by Neurocrine Biosciences, Inc.. The TYDESSIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, dystonia, movement disorders, and tics
tydessia

General Information

Serial Number86850072
Word MarkTYDESSIA
Filing DateTuesday, December 15, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 26, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, dystonia, movement disorders, and tics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 21, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, August 26, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 26, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, January 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2019EXTENSION 5 GRANTED
Wednesday, January 9, 2019EXTENSION 5 FILED
Thursday, January 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 9, 2019TEAS EXTENSION RECEIVED
Friday, October 12, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 12, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2018EXTENSION 4 GRANTED
Friday, July 20, 2018EXTENSION 4 FILED
Friday, July 20, 2018TEAS EXTENSION RECEIVED
Friday, January 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 10, 2018EXTENSION 3 GRANTED
Wednesday, January 10, 2018EXTENSION 3 FILED
Wednesday, January 10, 2018TEAS EXTENSION RECEIVED
Saturday, June 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 1, 2017EXTENSION 2 GRANTED
Thursday, June 1, 2017EXTENSION 2 FILED
Thursday, June 1, 2017TEAS EXTENSION RECEIVED
Thursday, January 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2017EXTENSION 1 GRANTED
Tuesday, January 10, 2017EXTENSION 1 FILED
Tuesday, January 10, 2017TEAS EXTENSION RECEIVED
Tuesday, July 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 25, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 13, 2016ASSIGNED TO LIE
Saturday, March 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 25, 2016EXAMINER'S AMENDMENT ENTERED
Friday, March 25, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 25, 2016EXAMINERS AMENDMENT E-MAILED
Friday, March 25, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 17, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 17, 2016NON-FINAL ACTION E-MAILED
Wednesday, February 17, 2016NON-FINAL ACTION WRITTEN
Wednesday, February 10, 2016ASSIGNED TO EXAMINER
Monday, December 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 18, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

tydessia disorders insomnia endometriosis diseases related psychiatric immune system uterine fibroids